HARRY J. GOULD, MD
Psychiatric at Poydras St, New Orleans, LA

License number
Louisiana 020854
Category
Neurology
Type
Neurology
License number
Louisiana 020854
Category
Psychiatric
Type
Pain Medicine
Address
Address
1450 Poydras St, New Orleans, LA 70112
Phone
(504) 903-1932
(504) 412-1835

Personal information

See more information about HARRY J. GOULD at radaris.com
Name
Address
Phone
Harry Gould
18142 Magnolia Bridge Rd, Greenwel Spgs, LA 70739
Harry Gould
744 Stoney Creek Ave, Baton Rouge, LA 70808
Harry Gould
2020 Gravier St, New Orleans, LA 70112
Harry Gould
104 Paradise Pt, Slidell, LA 70461
Harry Gould
103 Paradise Pt, Slidell, LA 70461

Organization information

See more information about HARRY J. GOULD at bizstanding.com

Harry J Gould Iii MD

1400 Poydras St #C, New Orleans, LA 70112

Categories:
Neurology Physicians & Surgeons
Phone:
(504) 903-1923 (Phone)

Professional information

Harry J Gould Photo 1

Harry J Gould, New Orleans LA

Specialties:
Neurologist
Address:
1450 Poydras St, New Orleans, LA 70112
1542 Tulane Ave, New Orleans, LA 70112
Education:
Louisiana State University, School of Medicine (New Orleans) - Doctor of Medicine
Brown University - Doctor of Philosophy
LSU Interim Hospital - Residency - Neurology
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Pain Medicine (Psychiatry and Neurology)


Harry J Gould Photo 2

Harry J Gould, New Orleans LA

Specialties:
Neurology, Pain Medicine, Pain Medicine, Cardiovascular Disease
Work:
Lsu Healthcare Network
2820 Napoleon Ave, New Orleans, LA 70115 Lsu Healthcare Network
1542 Tulane Ave, New Orleans, LA 70112 Lsu Healthcare Network
1450 Poydras St, New Orleans, LA 70112 Lsu Healthcare Network
2020 Gravier St, New Orleans, LA 70112 Lsu Healthcare Network
3401 North Blvd, Baton Rouge, LA 70806
Education:
Louisiana State University at New Orleans (1990)


Harry Gould Photo 3

Targeted Osmotic Lysis Of Cancer Cells

US Patent:
2013018, Jul 18, 2013
Filed:
Jul 19, 2012
Appl. No.:
13/552909
Inventors:
Dennis J. Paul - New Orleans LA, US
Harry J. Gould - New Orleans LA, US
International Classification:
A61K 31/7048, A61N 1/36, A61K 45/06
US Classification:
514 174, 514 26, 514279, 514450, 514171, 514216, 514729, 514460, 514366, 514521, 514511, 514456, 607116
Abstract:
A targeted osmotic lysis (TOL) of tumor cells that over-express voltage-gated sodium channels (VGSCs) has been developed that uses a combined therapy of a drug that blocks sodium, potassium-adenosine triphosphatase (Na, K-ATPase) that is then followed by an activation of VGSCs, for example, by electrical or pharmacological stimulation. Activation of VGSCs conducts sodium into the cancer cells in much greater amounts than non-cancer cells. Water follows this sodium gradient into the cancer cells, causing swelling and lysis. Because non-cancerous cells do not over-express VGSCs, less sodium and less water will enter the cells, and the non-cancerous cells will not lyse. This method is applicable to all cells that over-express VGSCs, including, but not limited to, highly invasive breast cancer, prostate cancer, small cell lung cancer, non-small cell lung carcinoma, lymphoma, mesothelioma, neuroblastoma, and cervical cancer.